Interestingly, our CTC profiling at baseline pointed out as relevant cell signaling pathways for CTC biology, such as ERK, AKT, P53, and NFKB, all of them classical tumor driver pathways in cancer [39,40,41]. The gene discussed is NFKB1; the disease is neoplasm.